MedTrace Logo

Imaging Features for the Risks for Recurrence After Stereotactic Radiosurgery in Brain Metastasis

NCT05868928 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 132

Last updated 2024-05-14

No results posted yet for this study

Summary

This trial uses multi-parametric magnetic resonance imaging (MRI) to develop and validate imaging risk score to predict radiation necrosis in participants with brain metastasis treated with radiation therapy. Diagnostic procedures, such as multi-parametric magnetic resonance imaging (MRI), may improve the ability to diagnose radiation necrosis early and help establish treatment strategies.

Conditions

Interventions

DIAGNOSTIC_TEST

Magnetic resonance imaging (MRI)

Pre-and post-contrast enhanced T1-weighted image, T2-weighted image, fluid-attenuated inversion recovery image

DIAGNOSTIC_TEST

Diffusion-weighted MRI

Diffusion-weighted MRI

DIAGNOSTIC_TEST

Arterial spin labeling (ASL)

Cerebral blood flow imaging parameter

DIAGNOSTIC_TEST

Dynamic susceptibility contrast-MRI (DSC-MRI)

Cerebral blood volume and vessel architectural imaging parameters

Sponsors & Collaborators

  • Asan Medical Center

    lead OTHER

Principal Investigators

  • Ho Sung Kim, MD, PhD · Asan Medical Center

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-12-07
Primary Completion
2026-07-30
Completion
2026-07-30

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05868928 on ClinicalTrials.gov